162 related articles for article (PubMed ID: 35278815)
21. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G
J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623
[TBL] [Abstract][Full Text] [Related]
22. Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma.
Li J; Zhao YH; Tian SF; Xu CS; Cai YX; Li K; Cheng YB; Wang ZF; Li ZQ
CNS Neurosci Ther; 2021 Dec; 27(12):1483-1492. PubMed ID: 34605602
[TBL] [Abstract][Full Text] [Related]
23. Cortactin, fascin and survivin expression associated with clinicopathological parameters in brain gliosarcoma.
Chen JH; Chen KY; Ma HI; Yu CP; Nieh S; Lee HS; Jin JS
Chin J Physiol; 2010 Aug; 53(4):234-44. PubMed ID: 21793333
[TBL] [Abstract][Full Text] [Related]
24. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
[TBL] [Abstract][Full Text] [Related]
25. [Secondary gliosarcoma: case report].
Tahri R; Boulahroud O; Setti K; Oukabli M; El Ochi MR; Akhaddar A; Boucetta M; Albouzidi A
Ann Pathol; 2012 Apr; 32(2):147-50. PubMed ID: 22520611
[TBL] [Abstract][Full Text] [Related]
26. Gliosarcoma cerebri with a myxoid matrix of the sarcomatous component.
Panayiotides JG; Arapantoni-Dadioti P; Lekka-Katsoulic J; Mariatos P; Delides GS
Rom J Morphol Embryol; 1994; 40(1-2):45-50. PubMed ID: 7640376
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
28. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells.
Biernat W; Aguzzi A; Sure U; Grant JW; Kleihues P; Hegi ME
J Neuropathol Exp Neurol; 1995 Sep; 54(5):651-6. PubMed ID: 7666053
[TBL] [Abstract][Full Text] [Related]
29. Temporal gliosarcoma with extraneural metastasis: case report.
Maeda D; Miyazawa T; Toyooka T; Shima K
Neurol Med Chir (Tokyo); 2010; 50(4):343-5. PubMed ID: 20448433
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
31. Gliosarcoma: report of four cases with immunohistochemical findings.
Machuca TN; Prevedello DM; Pope LZ; Haratz SS; Araújo JC; Torres LF
Arq Neuropsiquiatr; 2004 Sep; 62(3A):608-12. PubMed ID: 15334217
[TBL] [Abstract][Full Text] [Related]
32. Gliosarcoma case report and review of the literature.
Awadalla AS; Al Essa AM; Al Ahmadi HH; Al Ojan A; Muazen Y; Alsayyah A; Alsaif H; Alsafwani NS
Pan Afr Med J; 2020; 35():26. PubMed ID: 32341747
[TBL] [Abstract][Full Text] [Related]
33. Gliosarcoma with liposarcomatous component, bone infiltration and extracranial growth.
Borota OC; Scheie D; Bjerkhagen B; Jacobsen EA; Skullerud K
Clin Neuropathol; 2006; 25(4):200-3. PubMed ID: 16866302
[TBL] [Abstract][Full Text] [Related]
34. Postradiation gliosarcoma with osteosarcomatous components.
Lieberman KA; Fuller CE; Caruso RD; Schelper RL
Neuroradiology; 2001 Jul; 43(7):555-8. PubMed ID: 11512585
[TBL] [Abstract][Full Text] [Related]
35. Gliosarcomas with the
Wang L; Sun J; Li Z; Chen L; Fu Y; Zhao L; Liu L; Wei Y; Teng L; Lu D
J Clin Pathol; 2017 Dec; 70(12):1079-1083. PubMed ID: 28775171
[TBL] [Abstract][Full Text] [Related]
36. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.
Boerman RH; Anderl K; Herath J; Borell T; Johnson N; Schaeffer-Klein J; Kirchhof A; Raap AK; Scheithauer BW; Jenkins RB
J Neuropathol Exp Neurol; 1996 Sep; 55(9):973-81. PubMed ID: 8800093
[TBL] [Abstract][Full Text] [Related]
37. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
[TBL] [Abstract][Full Text] [Related]
38. Primary gliosarcoma of the brain: radiologic and histopathologic features.
Romero-Rojas AE; Diaz-Perez JA; Ariza-Serrano LM; Amaro D; Lozano-Castillo A
Neuroradiol J; 2013 Dec; 26(6):639-48. PubMed ID: 24355182
[TBL] [Abstract][Full Text] [Related]
39. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
[TBL] [Abstract][Full Text] [Related]
40. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
